IRF4 rs12203592 Risk Variant shows Effect in European but not in Non-European and Admixed Myelodysplastic Neoplasm Patients

Gusmão, Jonas Nogueira Ferreira Maciel; Chaves, Alessandro Cavalcante; Goes, João Vitor Caetano; Pinheiro, Ronald Feitosa; Júnior, Howard Lopes Ribeiro

IRF4 rs12203592 Risk Variant shows Effect in European but not in Non-European and Admixed Myelodysplastic Neoplasm Patients [Turk J Hematol]

Turk J Hematol. Ahead of Print: TJH-47427 | DOI: 10.4274/tjh.galenos.2025.2024.0386

IRF4 rs12203592 Risk Variant shows Effect in European but not in Non-European and Admixed Myelodysplastic Neoplasm Patients

Jonas Nogueira Ferreira Maciel Gusmão¹, Alessandro Cavalcante Chaves², João Vitor Caetano Goes³, Ronald Feitosa Pinheiro², Howard Lopes Ribeiro Júnior⁴
¹Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil
²Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil
³Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil; Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil
⁴Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil; Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil; Post-Graduate Program of Translational Medicine, Federal University of Ceara, Fortaleza, Ceara, Brazil

Keywords: IRF4, Myelodysplastic Neoplasm, Polymorphism, Risk

Corresponding Author: Jonas Nogueira Ferreira Maciel Gusmão
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Similar articles PubMed Google Scholar